Table 1.

Clinicopathological characteristics of gastric cancer patients between MET4 staining positive and negative

Characteristic	Total	MET4		P
		Positive	Negative
Number of patients	201	138	63	–
Sex
Male	149	103	46	0.808
Female	52	35	17
Age at diagnosis	65 (36–89)	66.0 ± 11.2	61.9 ± 9.5	0.012
Maximum tumor diameter (mm)	66.9 ± 39.6	68.6 ± 40.0	63.1 ± 38.6	0.360
Tumor lesion
Upper	51	37	14	0.224
Middle	75	46	29
Lower	75	55	20
Clinical stage
I	24	12	12	0.202
II	56	41	15
III	72	50	22
IV	49	35	14
Depth of invasion
T1 (M, SM)	16	9	7	0.318
T2 (MP)	36	25	11
T3 (SS)	59	37	22
T4 (SE, SI)	90	67	23
Lymph node metastasis
N0	34	19	15	0.180
N1 (1–2)	45	33	12
N2 (3–6)	48	32	16
N3 (≥7)	73	54	19
NX	1	0	1
Histology of peritoneal lavage
CYX/0	172	114	58	0.077
CY1	29	24	5
Peritoneal dissemination
P0	169	113	56	0.208
P1	32	25	7
Residual tumor
R0	150	101	49	0.488
R1	51	37	14
Postoperative chemotherapy
Yes	20	12	8	0.379
No	181	126	55
Histological type
Differentiated type	83	69	14	0.0002
Undifferentiated type	118	69	49
Stromal type
med	10	8	2	0.302
int	130	93	37
sci	60	36	24
Unknown	1	1	0
INF
a	9	6	3	0.012
b	98	78	20
c	92	53	39
Unknown	2	1	1
Lymphatic invasion
ly0	4	2	2	0.019
ly1	78	45	33
ly2	77	62	15
ly3	42	29	13
Venous invasion
v0	37	16	21	0.0003
v1	91	61	30
v2	57	47	10
v3	16	14	2

P values less than 0.05 are underlined.